Time to treat polycystic kidney diseases like the neoplastic disorders that they are

Kidney International

Volumn 57, Issue 1, 2000, Pages 339-340

  Grantham, J J ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cyst; Epithelial growth factor; Polycystic disease; Tyrosine kinase activation

Indexed keywords

ANTINEOPLASTIC AGENT; EKI 785; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; POLYCYSTIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AUTOPHOSPHORYLATION; AUTOSOMAL DOMINANT DISORDER; CANCER INHIBITION; CHROMOSOME 16; CHROMOSOME 4; CHROMOSOME 6; EDITORIAL; GENE EXPRESSION; GENE MUTATION; KIDNEY POLYCYSTIC DISEASE; NEOPLASM; PARENCHYMA; PRIORITY JOURNAL; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

EID: 0034049851     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00849.x     Document Type: Editorial

References (10)

1. V.E. Torres New insights into polycystic kidney disease and its treatment Curr Opin Nephrol Hypertens 7 1998 159 169
2. R. Mangoo-Karim M.E. Uchic M. Grant W.A. Shumate J.P. Calvet C.H. Park J.J. Grantham Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP FASEB J 3 1989 2629 2632
3. D.D. Woo S.Y. Miao J.C. Pelayo A.S. Woolf Taxol inhibits progression of congenital polycystic kidney disease Nature 368 1994 750 753
4. J.R. Martinez B.D. Cowley Vh Gattone II S. Nagao T. Yamaguchi S. Kaneta H. Takahashi J.J. Grantham The effect of paclitaxel on the progression of polycystic kidney disease in rodents Am J Kidney Dis 29 1997 435 444
5. C.S. Sommardahl R.P. Woychik W.E. Sweeney E.D. Avner J.E. Wilkinson Efficacy of taxol in the orpk mouse model of polycystic kidney disease Pediatr Nephrol 11 1997 728 733 10.1007/s004670050376
6. N.S. Murcia We Sweeney Jr E.D. Avner New insights into the molecular pathophysiology of polycystic kidney disease Kidney Int 55 1999 1187 1197
7. W.E. Sweeney L. Futey P. Frost E.D. Avner In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor Kidney Int 56 1999 406 413
8. W.E. Sweeney Y. Chen K. Nakanishi P. Frost E.D. Avner Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor Kidney Int 57 2000 33 40
9. V.H. Gattone J.P. Calvet Murine infantile polycystic kidney disease: A role for reduced renal epidermal growth factor Am J Kidney Dis 17 1991 606 607
10. V.H. Gattone D.A. Lowden B.D. Cowley Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice Dev Biol 169 1995 504 510 10.1006/dbio.1995.1164